LYNCH John Edward
SEC CIK 1865686 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IGC | IGC Pharma, Inc. | Dir | 134.4K | — | — | 1 | 2022-05-31 | 2022-05-31 |
Most active insiders at IGC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moran James P | Dir | — | — |
| 2 | GRIMALDI CLAUDIA | PFO, Dir | — | — |
| 3 | PRINS RICHARD K | Dir | — | — |
| 4 | Mukunda Ram | CEO, Dir | — | — |
LYNCH John Edward made no open-market trades at IGC in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-28 | 2022-05-31+ | IGC | IGC Pharma, Inc. | LYNCH John Edward | Dir | M - OptEx | $0.00 | +37.5K | 134.4K | +39% | $0 |
Purchase Sale Sale after option exercise All abbreviations